Qubit Pharmaceuticals is a brand-new international company, spun off from CNAM, CNRS, University of Texas at Austin, Sorbonne University and Washington University, and based in Paris. Qubit Pharmaceuticals builds upon more than 20 years of R&D awarded by the most prestigious prizes.

Qubit Pharmaceuticals is supported by Quantonation, a leading investment fund in quantum technologies in its mission to revolutionize the way drugs are developed and provide safer and more efficient drugs faster.

Qubit Pharmaceuticals is laureate of the EIT health headstart program and incubated at Paris Biotech Santé.

The Founders

Pr Jay Ponder
Pr Jay PonderWashington University in St. Louis, Chemistry and Biochemistry & Molecular Biophysics
Read Bio
Pr Pengyu Ren
Pr Pengyu Ren University of Texas at Austin, Biomedical Engineering
Read Bio
Pr J.-P. Piquemal, CSO
Pr J.-P. Piquemal, CSOSorbonne Université, Laboratoire de Chimie Théorique
Read Bio
Dr Louis Lagardère
Dr Louis LagardèreSorbonne Université, Laboratoire de Chimie Théorique
Read Bio
Pr Matthieu Montes
Pr Matthieu MontesCNAM, Laboratoire de génomique, bioinformatique et chimie moléculaire
Read Bio

The Team

Chris Ho, MD PhD
Chris Ho, MD PhDVP Bus dev & application
Read Bio
Christophe Jurczak, PhD
Christophe Jurczak, PhDNon Executive President
Read Bio
Robert Marino, PhD
Robert Marino, PhDCEO
Read Bio